Close

COG7

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

COG7 (Component Of Oligomeric Golgi Complex 7) is a Protein Coding gene. Diseases associated with COG7 include Congenital Disorder Of Glycosylation, Type Ii and Congenital Disorder Of Glycosylation, Type In. Among its related pathways are Transport to the Golgi and subsequent modification and Metabolism of proteins.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-CQ0591 Anti-COG7 (CBXC-0502) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXC-0502 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ0592 Anti-COG7 (CBXC-0501) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXC-0501 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4015 Anti-COG7 (CBXC-0502) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXC-0502 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4016 Anti-COG7 (CBXC-0501) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXC-0501 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY2925 Anti-COG7 (CBFYC-2029) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBFYC-2029 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY6178 Anti-COG7 (CBFYC-2029) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBFYC-2029 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ0543 Anti-COG7 (CBWJC-2899) h(41BB-CD3ζ) CAR, pCDCAR1 CBWJC-2899 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ2835 Anti-COG7 (CBWJC-2899) h(CD28-CD3ζ) CAR, pCDCAR1 CBWJC-2899 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.